Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
IssueQ22018
25 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Biologics
Building a Biologics Business from the Ground Up
PAP-Q2-18-CL-008
Hot Melt Extrusion
Leveraging Hot Melt Extrusion for Solubility and Continuous Manufacturing
PAP-Q2-18-CL-007
Mergers & Acquisitions
Inside Mergers & Acquisitions
PAP-Q2-18-CL-001
Next-Generation Biopharma
Changes in the Biopharma Industry: from Minor to Major Evolution
PAP-Q2-18-NI-002
Clinical Trials
Supporting Patient-Centric Clinical Trials from Point-of-Origin through the Last Mile
PAP-Q2-18-CL-002
Investment
Taking Middle-Market CROs and CDMOs to the Next Level
PAP-Q2-18-CL-003
Biologic Candidates
Addressing Development Challenges for Complex Biologic Drug Candidates
PAP-Q2-18-CL-004
Viral Vector
Flexible, Mobile, Modular: High-Containment Viral Vector Center of Excellence
PAP-Q2-18-CL-005
Contract Manufacturing Needs
Meeting Biopharma Contract Manufacturing Needs with a Flexible Global Network
PAP-Q2-18-CL-006
Multi-Product Facility Manufacturing
Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility
PAP-Q2-18-CL-009
GMP
State-of-the-Art Biologics Manufacturing in an Unexpected Location
PAP-Q2-18-CL-010
Cell and Gene Therapy
Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing
PAP-Q2-18-CL-011
OSD Facility Design
Modern OSD Facility Design Considerations for Operational Efficiency and Regulatory Compliance
PAP-Q2-18-CL-012
Integration
Strengthening the Outsource Service Offering through Integration
PAP-Q2-18-CL-013
Corporate Social Responsibility
Corporate Social Responsibility as a Driver for Improved Sustainability
PAP-Q2-18-CL-014
Next-Generation Drug Development
Challenges for Next-Generation Biological Therapeutics in Discovery and Development
PAP-Q2-18-FA-001
Next-Generation Manufacturing
Thinking a Generation Ahead: Biologics-Based Therapy
PAP-Q2-18-FA-002
Next-Generation Packaging
Finishing Touches – The Future of Fill-Finish and Pharma Packaging
PAP-Q2-18-FA-003
Asset Management
Maximizing ROI through Equipment Liquidation
PAP-Q2-18-CL-015
Solid Oral Dosage Drugs
Experience Meets Flexibility
PAP-Q2-18-CL-016
Oral Peptides
Scientific Expertise Facilitates Oral Peptide Product Development and Manufacturing
PAP-Q2-18-CL-017
Controlled Nucleation
Achieving Controlled Nucleation During Aseptic Lyophilization
PAP-Q2-18-CL-018
Market Expansion
BioPharma CDMO Success Requires Technical Leadership and Problem-Solving Capabilities
PAP-Q2-18-CL-019
Fill-Finish Services
Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services
PAP-Q2-18-CL-020
1
2
»